
VNDA
Healthcare · Biotechnology · $241.3M market cap
$3.99+0.04 (+1.0%)Nov 13, 4:04 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +16.7% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 28, 2026 | After the close | -0.72 | -0.37 | +48.6% |
| Aug 5, 2026 | After the close | -0.51 | -1.04 | -103.9% |
| May 6, 2026 | After the close | -0.69 | -0.82 | -18.8% |
| Feb 11, 2026 | After the close | -1.32 | -2.39 | -81.1% |
| Oct 29, 2025 | After the close | -0.45 | -0.38 | +15.6% |
| Jul 31, 2025 | Before the open | -0.36 | -0.46 | -27.8% |
| May 7, 2025 | After the close | -0.60 | -0.50 | +16.7% |
| Feb 13, 2025 | After the close | -0.11 | -0.08 | +27.3% |
| Nov 6, 2024 | After the close | -0.16 | -0.09 | +43.8% |
| Jul 31, 2024 | After the close | -0.21 | -0.08 | +61.9% |
| May 9, 2024 | Before the open | 0.05 | -0.07 | -240.0% |
| Feb 7, 2024 | After the close | -0.09 | -0.04 | +55.6% |
| Nov 8, 2023 | After the close | -0.04 |
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep…
| 0.00 |
| +106.0% |
| Jul 27, 2023 | After the close | -0.13 | 0.03 | +123.1% |
| May 3, 2023 | After the close | 0.06 | 0.06 | 0.0% |
| Feb 8, 2023 | After the close | 0.08 | 0.12 | +50.0% |
| Nov 2, 2022 | After the close | 0.09 | 0.06 | -33.3% |
| Aug 3, 2022 | After the close | 0.12 | 0.05 | -58.3% |
| May 5, 2022 | After the close | -0.01 | -0.11 | -1000.0% |
| Feb 23, 2022 | After the close | 0.09 | 0.12 | +33.3% |
| Nov 3, 2021 | After the close | 0.18 | 0.14 | -22.2% |
| Jul 28, 2021 | After the close | 0.11 | 0.17 | +54.5% |
| May 5, 2021 | After the close | 0.14 | 0.15 | +7.1% |
| Feb 10, 2021 | After the close | 0.14 | 0.15 | +7.1% |
| Oct 28, 2020 | After the close | 0.10 | 0.11 | +10.0% |
| Aug 5, 2020 | After the close | 0.06 | 0.16 | +166.7% |
| May 6, 2020 | After the close | 0.01 | 0.09 | +800.0% |
| Feb 25, 2020 | After the close | 0.11 | 0.08 | -27.3% |
| Nov 6, 2019 | After the close | 0.07 | 1.91 | +2628.6% |
| Jul 31, 2019 | After the close | 0.05 | 0.28 | +460.0% |
| May 1, 2019 | After the close | 0.07 | 0.06 | -14.3% |
| Feb 13, 2019 | After the close | 0.13 | 0.26 | +100.0% |
| Nov 7, 2018 | After the close | 0.01 | 0.20 | +1900.0% |
| Aug 1, 2018 | After the close | 0.02 | 0.14 | +600.0% |
| May 2, 2018 | After the close | -0.04 | 0.14 | +450.0% |
| Feb 14, 2018 | After the close | -0.05 | 0.03 | +160.0% |